Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
primary studies published RCT
Details- 2010
- Saiman L
Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis.
primary studies published RCT
Details- 2010
- Sermet-Gaudelus I
Garlic as an inhibitor of Pseudomonas aeruginosa quorum sensing in cystic fibrosis--a pilot randomized controlled trial.
primary studies published RCT
Details- 2010
- Smyth AR
Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis.
primary studies published RCT
Details- 2010
- Sontag MK
Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
primary studies published RCT
Details- 2010
- Tramper-Stranders GA
Acapella vs. PEP mask therapy: a randomised trial in children with cystic fibrosis during respiratory exacerbation.
primary studies published RCT
Details- 2010
- West K
Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF).
primary studies published RCT
Details- 2009
- Chapman I
A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis.
primary studies published RCT
Details- 2009
- Dauletbaev N
Long-term clarithromycin in cystic fibrosis: effects on inflammatory markers in BAL and clinical status.
primary studies published RCT
Details- 2009
- Dogru D
Pulmonary delivery of tobramycin by an investigational EFlow electronic nebulizer saves 50% of the drug, and results in equivalent or improved tobramycin safety levels in plasma and sputum [abstract].
primary studies published RCT
Details- 2009
- Griese M